Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Bevacizumab × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 104 Carcinoma, Hepatocellular 59 Ovarian Neoplasms 56 Carcinoma, Non-Small-Cell Lung 36 Neoplasms 31 Fallopian Tube Neoplasms 25 Colonic Neoplasms 21 Endometrial Neoplasms 19 Breast Neoplasms 19 Brain Neoplasms 18 Neoplasm Metastasis 15 Glioblastoma 15 Uterine Cervical Neoplasms 14 Stomach Neoplasms 14 Rectal Neoplasms 13 Lung Neoplasms 12 Liver Neoplasms 11 Triple Negative Breast Neoplasms 10 Melanoma 10 Colorectal Cancer Metastatic 8 Carcinoma, Renal Cell 8 Recurrence 7 Carcinoma, Ovarian Epithelial 7 Advanced Solid Tumors 7 Squamous Cell Carcinoma of Head and Neck 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Biliary Tract Neoplasms 6 Small Cell Lung Carcinoma 5 Pancreatic Neoplasms 5 Gastrointestinal Neoplasms 5

Interventions

Cyclophosphamide 80 Rituximab 77 Prednisone 45 Doxorubicin 39 Lenalidomide 35 Vincristine 32 fludarabine 27 polatuzumab vedotin 25 Magnetic Resonance Spectroscopy 24 Gemcitabine 23 Etoposide 23 Specimen Handling 22 Oxaliplatin 19 Biopsy 18 CT-P10 17 glofitamab 15 zanubrutinib 14 ibrutinib 13 fludarabine phosphate 13 tafasitamab 12 obinutuzumab 12 axicabtagene ciloleucel 12 venetoclax 10 pembrolizumab 10 deltacortene 10 Bendamustine Hydrochloride 10 prednylidene 9 Prednisolone 9 Nivolumab 9 Immunotherapy, Adoptive 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡